Compare Gaush Meditech Ltd. with Similar Stocks
Dashboard
1
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 0%
- Poor long term growth as Net Sales has grown by an annual rate of -4.99% and Operating profit at -205.29% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
2
Flat results in Jun 25
3
Risky -
4
Consistent Underperformance against the benchmark over the last 3 years
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-17.43%
0%
-17.43%
6 Months
-47.67%
0%
-47.67%
1 Year
-61.54%
0%
-61.54%
2 Years
-85.99%
0%
-85.99%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Gaush Meditech Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-4.99%
EBIT Growth (5y)
-205.29%
EBIT to Interest (avg)
-4.94
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.03
Tax Ratio
7.60%
Dividend Payout Ratio
44.27%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.70
EV to EBIT
-162.79
EV to EBITDA
-407.24
EV to Capital Employed
0.70
EV to Sales
15.16
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-0.43%
ROE (Latest)
-0.34%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
1,548.70
1,553.90
-0.33%
Operating Profit (PBDIT) excl Other Income
302.90
365.70
-17.17%
Interest
39.80
55.90
-28.80%
Exceptional Items
-24.50
3.90
-728.21%
Consolidate Net Profit
96.00
191.10
-49.76%
Operating Profit Margin (Excl OI)
138.20%
181.30%
-4.31%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -0.33% vs 6.58% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -49.76% vs 146.59% in Dec 2023
About Gaush Meditech Ltd. 
Gaush Meditech Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






